PAYS Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

21.54M

+38.04%

0.020

23.83M

+28.13%

0.055

+10%

23.92M

+25.37%

0.045

+125%

Estimates Revision

The market is revising Upward the revenue expectations for Paysign, Inc. (PAYS) for FY2025, with the revenue forecasts being adjusted by 3.41% over the past three months. During the same period, the stock price has changed by -12.39%.

Revenue Estimates for FY2025

Revise Upward

+3.41%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Down

-12.39%

In Past 3 Month

4 Analyst Rating

Wall Street analysts forecast PAYS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PAYS is 9.00 USD with a low forecast of 8.50 USD and a high forecast of 10.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

0 Sell

Strong Buy

Current: 0.000

Low

8.50

Averages

9.00

High

10.00

Current: 0.000

Low

8.50

Averages

9.00

High

10.00

Lake Street

Jacob Stephan

Buy

maintain

$9 -> $10

2025-08-06

Reason

Lake Street

Jacob Stephan

Price Target

$9 -> $10

2025-08-06

maintain

Buy

Reason

Lake Street analyst Jacob Stephan raised the firm's price target on Paysign to $10 from $9 and keeps a Buy rating on the shares after the company reported a beat and raise quarter. Paysign is "in the early innings of an inflection in pharma revenues," according to the analyst, who believes "investors should take note."

Barrington

Outperform

maintain

2025-06-30

Reason

Barrington

Price Target

2025-06-30

maintain

Outperform

Reason

Barrington raised the firm's price target range on Paysign to $8-$9 from a prior range of $6-$7 and keeps an Outperform rating on the shares. The firm cites the "strong outlook" for Paysign's Patient Affordability segment for the pharmaceutical industry for its target hike.

Lake Street

Jacob Stephan

Buy

maintain

$7 -> $9

2025-06-26

Reason

Lake Street

Jacob Stephan

Price Target

$7 -> $9

2025-06-26

maintain

Buy

Reason

Lake Street analyst Jacob Stephan raised the firm's price target on Paysign to $9 from $7 and keeps a Buy rating on the shares after having hosted CFO Jeff Baker for investor meetings earlier this week. The firm came away from the meetings "feeling confident" in Paysign's pharma pipeline, scalable operating model, and new plasma applications, the analyst tells investors.

DA Davidson

Peter Heckmann

Buy

maintain

$7 -> $8

2025-06-13

Reason

DA Davidson

Peter Heckmann

Price Target

$7 -> $8

2025-06-13

maintain

Buy

Reason

DA Davidson analyst Peter Heckmann raised the firm's price target on Paysign to $8 from $7 and keeps a Buy rating on the shares. Last week, Paysign announced the company had been awarded 132 established plasma donation centers through an expansion of a relationship with a major plasma collection company, and the firm believes this will increase the company's total plasma locations to 613 centers, a 27% increase over the 484 locations served at the end of Q1, the analyst tells investors in a research note.

Barrington

NULL -> Outperform

maintain

2025-05-22

Reason

Barrington

Price Target

2025-05-22

maintain

NULL -> Outperform

Reason

Barrington raised the firm's price target on Paysign to a range of $6.00-$7.00 from $5 and keeps an Outperform rating on the shares after Q1 results were better than the firm's as well as consensus expectations. Following the Q1 report, the firm is increasing its 2025 and 2026 adjusted EBITDA estimates to $16.0M and $19.1M from $12.5M and $15.3M, respectively.

DA Davidson

Peter Heckmann

Buy

maintain

$5 -> $6

2025-05-14

Reason

DA Davidson

Peter Heckmann

Price Target

$5 -> $6

2025-05-14

maintain

Buy

Reason

DA Davidson analyst Peter Heckmann raised the firm's price target on Paysign to $6 from $5 and keeps a Buy rating on the shares. The company reported impressive Q1 results, including 41% Y/Y growth in total revenue and 193% Y/Y growth in adjusted EBITDA, the analyst tells investors in a research note. The management also raised the midpoints of their prior guidance ranges for total revenue and adjusted EBITDA by 5% and 27%, respectively, the firm added.

Valuation Metrics

The current forward P/E ratio for Paysign Inc (PAYS.O) is 33.81, compared to its 5-year average forward P/E of -7.99. For a more detailed relative valuation and DCF analysis to assess Paysign Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-7.99

Current PE

33.81

Overvalued PE

284.68

Undervalued PE

-300.65

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

26.40

Current EV/EBITDA

11.26

Overvalued EV/EBITDA

52.68

Undervalued EV/EBITDA

0.13

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

3.39

Current PS

2.91

Overvalued PS

4.72

Undervalued PS

2.06

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 117.27% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 117.27% over the last month.

Sold

Bought

PAYS News & Events

Events Timeline

No data

News

4.0

2025-12-04NASDAQ.COM

Daily Upgrade Report for Validea Motley Fool Strategy - December 4, 2025

4.0

2025-11-25NASDAQ.COM

Reasons to Consider Paysign (PAYS) as a New Investment Opportunity

4.0

2025-11-07NASDAQ.COM

Daily Upgrade Report for Validea Motley Fool Strategy - November 7, 2025

People Also Watch

Frequently Asked Questions

What is Paysign Inc (PAYS) stock price today?

The current price of PAYS is 4.88 USD — it has increased 0.41 % in the last trading day.

What is Paysign Inc (PAYS)'s business?

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.

What is the price predicton of PAYS Stock?

What is Paysign Inc (PAYS)'s revenue for the last quarter?

Paysign Inc revenue for the last quarter amounts to 21.60M USD, increased 41.56 % YoY.

What is Paysign Inc (PAYS)'s earnings per share (EPS) for the last quarter?

Paysign Inc. EPS for the last quarter amounts to 0.04 USD, increased 33.33 % YoY.

What changes have occurred in the market's expectations for Paysign Inc (PAYS)'s fundamentals?

How many employees does Paysign Inc (PAYS). have?

Paysign Inc (PAYS) has 173 emplpoyees as of January 10 2026.

What is Paysign Inc (PAYS) market cap?

Today PAYS has the market capitalization of 268.61M USD.